))
The Inflation Reduction Act (IRA) of 2022: What Pharmaceutical Manufacturers Need to Know
Manage episode 371783624 series 2950783
Content provided by Mercalis. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Mercalis or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The Drug Provisions within the Inflation Reduction Act (IRA) of 2022 are of critical importance to pharmaceutical manufacturers, who now have a host of new considerations when thinking through their portfolio strategies and pricing and market access considerations. In this episode of TrialCard TALK, Landy and Eric welcome to the studio two experts on the topic: Megan Thomas, Partner, Triangle Insights Group and Jason Zemcik, Principal Consultant for Policy Reporter.
27 episodes
Share
